Overview

Breathe New Life into Pulmonary Care with Precision Pharmacogenomics

Personalize respiratory treatments, reduce complications, and enhance patient outcomes across your health system.

Overview

Pulmonary conditions such as asthma, COPD, and allergies can vary widely in patient response to therapy. PGxAI's Pulmonology module (PGxZephyr™) integrates genetic insights and real-world evidence to guide medication selection and dosing, reducing exacerbations and hospitalization rates. By analyzing key genetic markers, PGxZephyr™ helps pulmonologists tailor therapies—improving symptom control, minimizing side effects, and boosting long-term patient adherence.

•

20+ key pulmonary drugs covered, including corticosteroids, bronchodilators, antihistamines, and leukotriene modifiers.

•

15 critical genetic markers identified for precise respiratory care.

•

AI-driven recommendations update in real time, maximizing therapeutic benefits while minimizing risks.

Key Highlights

Serving every stakeholder in healthcare

Schedule a Demo Contact Us

Real-World Data Integration

Continuous AI learning from pulmonary outcomes ensures up-to-date recommendations for your care teams.

Reduced Flare-Ups & ER Visits

Precise dosing of bronchodilators and steroids mitigates severe exacerbations, cutting emergency care costs.

Targeted Therapy Selection

Personalize medication plans for asthma, COPD, and allergic conditions based on each patient's genetic profile.

Reimbursable Solutions

Aligned with standard CPT codes, PGx testing and consultations can be covered and billed effectively.

Clinical Impact

Maximize Clinical Impact with PGxAI

Schedule a Demo Contact Us

Precision-Guided Therapy Optimization

PGxAI mines genotype, phenotype, and comorbidity data in real time to recommend the optimal drug–dose pair at the first prescription. By accounting for actionable allelic variants and metabolic phenotypes, it minimizes trial-and-error titration and sharply reduces severe drug–gene and drug–drug interactions.

Superior Patient Outcomes & Experience

Genomically informed prescribing lowers adverse-event rates, accelerates therapeutic response, optimizes co-administered medications and boosts adherence. Patients spend less time managing side effects and more time benefiting from treatment, enhancing both clinical endpoints and satisfaction metrics across specialties.

Demonstrable Value-Based Performance

Fewer complications, shorter lengths of stay, and reduced readmissions translate into measurable gains on CMS and private-payer quality dashboards. Institutions leveraging PGxAI can document higher quality scores and capture value-based reimbursement upside while lowering total cost of care.

Seamless Team Integration & Scalability

The platform embeds directly into leading EHRs and e-prescribing systems, delivering concise, guideline-aligned reports that support rapid decision-making for multidisciplinary teams. Standardized APIs and CDS hooks allow effortless expansion from pilot units to enterprise-wide deployment without workflow disruption.

Drug Categories

PGxAI supports a range of respiratory therapies

Schedule a Demo Contact Us

Corticosteroids:

Fluticasone, Budesonide, Mometasone

Bronchodilators:

Salbutamol (Albuterol), Formoterol, Indacaterol

Antihistamines:

Fexofenadine, Desloratadine, Promethazine

Leukotriene Receptor Antagonists:

Montelukast, Zafirlukast

Methylxanthines:

Theophylline. Every recommendation is backed by validated genetic data (e.g., CYP3A4, ADRB2) and real-world clinical outcomes.

Case Study

Greenvale Pulmonary Clinic

Schedule a Demo Contact Us

Challenge

Frequent hospitalizations due to uncontrolled asthma exacerbations, high medication switch rates.

Solution

PGxZephyr™ integrated to analyze genetic markers and guide the selection of inhaled steroids and bronchodilators.

Results

35% reduction in severe asthma exacerbations over 9 months, improved patient adherence, and decreased ER visits.

What's next

Ready to Shape the Future of Precision Medicine?

Empower your pulmonology team with AI-driven insights that reduce exacerbations, lower healthcare costs, and elevate patient satisfaction.

Request a Demo

Learn how PGxZephyr™ can fit into your respiratory care workflows.